The days of building with anything in abundance are over,' says the co-founder of London-based structural engineering practice AKT II. 'But that doesn’t mean we should demonise steel and concrete ...

Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...